Results 71 to 80 of about 1,113 (188)

Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway

open access: yesFrontiers in Pharmacology, 2021
Xuebijing (XBJ), the only drug approved for the sepsis and multiple organ dysfunction, and its protective effects against acute liver injury (ALI) and its mechanism. The aim of this study was to evaluate the protective effect of XBJ on cecal ligation and
Liping Cao   +10 more
doaj   +1 more source

Antiviral effects and mechanism of Qi pi pill against influenza viruses

open access: yesAnimal Models and Experimental Medicine, Volume 8, Issue 8, Page 1364-1375, August 2025.
Qi pi pill presents anti‐influenza effect and inhibits viral replication in vitro by targeting both the viral RNA replication and the release of new viral particles. Furthermore, QPP modulates the production of proinflammatory cytokines induced by influenza infection in host cells.
Chengcheng Zhang   +10 more
wiley   +1 more source

Effect of Xuebijing injection on peripheral T-lymphocyte subpopulations in patients with severe trauma

open access: yes, 2010
ObjectiveTo investigate the effect and clinical significance of Xuebijing injection on peripheral T-lymphocyte subpopulations in patients with severe trauma.MethodsThirty-three patients with severe trauma were randomly divided into a control group (n=16)
LU, Yuan-qiang   +2 more
core   +1 more source

A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With “Long‐Covid‐19”

open access: yesPulmonary Circulation, Volume 15, Issue 2, April 2025.
ABSTRACT Bufei huoxue capsules (BFHX), manufactured products of traditional Chinese medicine, have demonstrated anti‐inflammatory properties and efficacy against chronic pulmonary diseases and COVID‐19. This study was designed to further determine the clinical efficacy of BFHX in diverse patient subgroups during the convalescent phase of COVID‐19 ...
Chi Hou   +24 more
wiley   +1 more source

Comprehensive characterization of Xuebijing injection and comparative analysis of its systemic exposure in patients with severe pneumonia, sepsis, and acute pancreatitis

open access: yesJournal of Chromatography Open
This study aimed to investigate the chemical constituents of Xuebijing injection and compare differences in its systemic exposure components among patients with severe pneumonia, sepsis, and acute pancreatitis during the steady-state blood concentration ...
Mingxin Guo   +5 more
doaj   +1 more source

Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis

open access: yesFrontiers in Pharmacology, 2020
The drug combination of biapenem (BIPM) and xuebijing injection (XBJ) is commonly applied for the treatment of sepsis in China. However, the potential synergistic mechanism is still enigmatic.
Li-Wei Liu   +29 more
doaj   +1 more source

Sepsis: the evolution of molecular pathogenesis concepts and clinical management

open access: yesMedComm, Volume 6, Issue 3, March 2025.
(A) The innate and adaptive immune responses established during long‐term evolution can eliminate most invading microorganisms. (B) Sepsis only occurs when the balance is disrupted and the pathogen force overwhelms the host's defense force. (C) Only when the superposition of external forces (sensitive antimicrobial drugs) and internal forces ...
Zhongxue Feng   +7 more
wiley   +1 more source

Protective effects of Dioscin against sepsis‐induced cardiomyopathy via regulation of toll‐like receptor 4/MyD88/p65 signal pathway

open access: yesImmunity, Inflammation and Disease, Volume 12, Issue 5, May 2024.
(1) Dioscin improved the myocardial tissue damage of SIC rat. (2) Dioscin improved LPS‐decreased the activities of SOD, CAT, and GSH. (3) Overexpressed TLR4 promoted the Dioscin‐suppressed the viability of H9c2 cell. Abstract Background Dioscin has many pharmacological effects; however, its role in sepsis‐induced cardiomyopathy (SIC) is unknown ...
Meng Zhang   +4 more
wiley   +1 more source

Xuebijing and somatostatin against acute pancreatitis: A systematic review and network pharmacology. [PDF]

open access: yesMedicine (Baltimore)
Background: Acute pancreatitis (AP) is a common pancreatic disease. Xuebijing injection (XBJ) combined with somatostatin in the treatment of AP is frequently used in clinical practice. There is, however, a lack of high-quality evidence-based evidence and network pharmacology to regard the therapeutic efficacy and ...
Cao JP, Piao XH, Zhu LX, Feng PF.
europepmc   +3 more sources

Plant‐derived compounds as potential leads for new drug development targeting COVID‐19

open access: yesPhytotherapy Research, Volume 38, Issue 3, Page 1522-1554, March 2024.
Abstract COVID‐19, which was first identified in 2019 in Wuhan, China, is a respiratory illness caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Although some patients infected with COVID‐19 can remain asymptomatic, most experience a range of symptoms that can be mild to severe. Common symptoms include fever, cough,
Lingxiu Liu, Maxim Kapralov, Mark Ashton
wiley   +1 more source

Home - About - Disclaimer - Privacy